Active

INTRACT PHARMA LIMITED Financials

Company number
09610219Copy
copy info iconCopy
Registered office
5 High Green, Great Shelford, Cambridge CB22 5EG
Incorporated
27/05/2015

Company snapshot

Status
Active
Employees
9 (2025)
Latest financial data
2025
Accounts type
Total Exemption Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2025.

Net Assets

£1.29M2025
335.30%vs 2024

2024: £295.92K

Total Assets

£1.51M2025
326.13%vs 2024

2024: £354.55K

Cash in Bank

£1.35M2025
473.67%vs 2024

2024: £235.94K

Total Liabilities

£166.11K2025
1.28K%vs 2024

2024: £12.04K

Employees

92025
+3vs 2024

2024: 6

In 2025, INTRACT PHARMA LIMITED reported net assets of £1.29M. The same filing shows total assets of £1.51M, cash in bank of £1.35M and total liabilities of £166.11K. Reported headcount was 9 in 2025. Total Assets rose from £354.55K in 2024 to £1.51M in 2025 (326.13%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£1.29M2025
335.30%from £295.92K in 2024

Year-on-year change

Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.

3-year financial trend (2023–2025)

How the figures INTRACT PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.

Net Assets

£650.55K2023£1.29M2025
+98%vs 2023

+40.7% a year compound (CAGR)

Cash in Bank

£546.78K2023£1.35M2025
+148%vs 2023

+57.3% a year compound (CAGR)

Total Assets

£787.28K2023£1.51M2025
+91.9%vs 2023

+38.5% a year compound (CAGR)

Total Liabilities

£79.02K2023£166.11K2025
+110%vs 2023

+45% a year compound (CAGR)

Employees

7202392025
+28.6%vs 2023+2

Biggest increase

Cash in Bank+148%

£546.78K in 2023 to £1.35M in 2025

Every indicator Okredo holds for INTRACT PHARMA LIMITED rose between 2023 and 2025. The steepest rise came in cash in bank, pointing to a more liquid cash position, with net assets, total assets, total liabilities and employee numbers climbing alongside it. See the full year-by-year figures.

Ratios from the filed figures

Calculated from INTRACT PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
85.26%2025

Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.

Liabilities to total assets
10.99%2025

Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.

Cash to liabilities
814.83%2025

Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.

Cash to total assets
89.59%2025

Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for INTRACT PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20212022202320242025
Net Assets£922.68K653.60K650.55K295.92K1.29M
Total Assets£1.08M761.74K787.28K354.55K1.51M
Cash in Bank£485.88K521.13K546.78K235.94K1.35M
Total Liabilities£25.95K20.99K79.02K12.04K166.11K
Employees08769

INTRACT PHARMA LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Has INTRACT PHARMA LIMITED filed financial statements?

toggle

Yes. Okredo holds filed figures for INTRACT PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.

What net assets did INTRACT PHARMA LIMITED report in 2025?

toggle

INTRACT PHARMA LIMITED reported net assets of £1.29M for 2025. That compares with £295.92K in 2024, a change of 335.30%.

What total assets did INTRACT PHARMA LIMITED report in 2025?

toggle

INTRACT PHARMA LIMITED reported total assets of £1.51M for 2025. That compares with £354.55K in 2024, a change of 326.13%.

What cash in bank did INTRACT PHARMA LIMITED report in 2025?

toggle

INTRACT PHARMA LIMITED reported cash in bank of £1.35M for 2025. That compares with £235.94K in 2024, a change of 473.67%.

How many people does INTRACT PHARMA LIMITED employ?

toggle

INTRACT PHARMA LIMITED reported 9 employees in 2025, compared with 6 in 2024.

How have INTRACT PHARMA LIMITED financials changed over the last 3 years?

toggle

Between 2023 and 2025, INTRACT PHARMA LIMITED's net assets rose by 98%, cash in bank rose by 148%, total assets rose by 91.9% and total liabilities rose by 110%. Net assets compounded at 40.7% a year across the two years to 2025, from £650.55K to £1.29M. Reported headcount went from 7 in 2023 to 9 in 2025 (+2).

Which years of INTRACT PHARMA LIMITED financial data are available?

toggle

Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.